glp-1 ibd GLPs as novel therapeutic options in IBD-potential mechanisms of action Gut Hormones and Inflammatory Bowel

Primary critical endpoint analysis The primary endpoint, mean venous umbilical cord blood erythrocyte GSH concentrations, was analyzed both in the FAS and PP populations using the nonparametric Kruskal-Wallis Test, without stratification for IPTB severity grade due to the small sample size

Acute kidney injury was graded according to the KDIGO classification [15]

Gallbladder problems: Symptoms can include pain in the upper abdomen, fever, yellowing of the skin or eyes (jaundice), or pale, clay-colored stools

142 Neutral antagonists have been suggested as a potentially safer alternative to Rimonabant in the treatment of obesity